Cazhap

Leaflet accompanying the packaging: patient information

Warning! The leaflet should be kept. Information on the immediate packaging in a foreign language.

Carzap

32 mg, tablets
Candesartan cilexetil

It is necessary to carefully read the contents of the leaflet before using the medicine, as it contains important information for the patient.

• The leaflet should be kept so that it can be re-read if necessary.
• In case of any doubts, the doctor or pharmacist should be consulted.
• This medicine has been prescribed to a specific person. It should not be given to others. The medicine may harm another person, even if the symptoms of their illness are the same.
• If the patient experiences any side effects, including any side effects not listed in this leaflet, they should inform their doctor, pharmacist, or nurse. See section 4.

Table of contents of the leaflet:

• 1. What is Carzap and what is it used for
• 2. Important information before taking Carzap
• 3. How to take Carzap
• 4. Possible side effects
• 5. How to store Carzap
• 6. Contents of the packaging and other information

1. What is Carzap and what is it used for

The name of the medicine is Carzap. The active substance of the medicine is candesartan cilexetil. It belongs to a group of medicines called angiotensin II receptor antagonists. It causes relaxation and dilation of blood vessels. This helps to lower blood pressure. The medicine also helps the heart pump blood to all parts of the body.

Carzap is used:

• to treat high blood pressure (hypertension) in adult patients and in children and adolescents from 6 to 18 years of age,
• in adult patients to treat heart failure with reduced cardiac function, when angiotensin-converting enzyme inhibitors (ACE inhibitors) cannot be used or as an addition to ACE inhibitor therapy when symptoms of heart failure persist despite treatment, and mineralocorticoid receptor antagonists (MRAs) cannot be used.

2. Important information before taking Carzap

When not to take Carzap

• If the patient is allergic to candesartan cilexetil or any of the other ingredients of this medicine (listed in section 6).
• If the patient is pregnant over 3 months (it is also recommended to avoid taking Carzap in early pregnancy - see section "Pregnancy and breastfeeding").
• If the patient has severe liver disease or biliary obstruction (obstruction of bile flow from the gallbladder).
• If the patient is a child under 1 year of age.
• If the patient has diabetes or kidney problems and is being treated with a blood pressure-lowering medicine containing aliskiren.

In case of doubt as to whether any of the above situations apply to the patient, the doctor or pharmacist should be consulted before taking Carzap.

Warnings and precautions

Before starting to take Carzap, the doctor or pharmacist should be consulted:

• If the patient has heart, liver, or kidney problems or is undergoing dialysis.
• If the patient has recently undergone a kidney transplant.
• If the patient has had vomiting or has had severe vomiting or diarrhea recently.
• If the patient has a disease of the adrenal glands called Conn's syndrome (primary hyperaldosteronism).
• If the patient has low blood pressure.
• If the patient has had a stroke.
• The doctor should be informed of any suspected or planned pregnancy. It is not recommended to take Carzap in early pregnancy and it should not be taken after 3 months of pregnancy, as it may seriously harm the baby (see section "Pregnancy").
• If the patient is taking any of the following medicines for high blood pressure:
• ACE inhibitors (e.g., enalapril, lisinopril, ramipril), especially if the patient has kidney problems related to diabetes.
• aliskiren.
• If the patient is taking an ACE inhibitor and a medicine belonging to a group of medicines known as mineralocorticoid receptor antagonists (MRAs) (see "Carzap and other medicines").

The doctor may monitor kidney function, blood pressure, and electrolyte levels (e.g., potassium) in the blood at regular intervals.

Children and adolescents

Studies have been conducted on the use of candesartan cilexetil in children. For further information, the doctor should be consulted. Carzap should not be given to children under 1 year of age due to the potential risk to kidney development.

Carzap and other medicines

The doctor or pharmacist should be told about all medicines the patient is taking or has recently taken, as well as any medicines the patient plans to take.

Carzap may affect the action of other medicines, and other medicines may affect Carzap. If the patient is taking certain medicines, the doctor may periodically recommend blood tests.

In particular, the doctor should be informed if the patient is taking any of the following medicines:

• other blood pressure-lowering medicines, including beta-blockers, diazoxide, and ACE inhibitors, such as enalapril, captopril, lisinopril, or ramipril;
• non-steroidal anti-inflammatory medicines (NSAIDs), such as ibuprofen, naproxen, diclofenac, celecoxib, or etoricoxib (medicines that relieve pain and inflammation);
• acetylsalicylic acid (in doses greater than 3 g per day) (a medicine that relieves pain and inflammation);
• potassium supplements, salt substitutes containing potassium (medicines that increase potassium levels in the blood);
• heparin (a blood-thinning medicine);
• co-trimoxazole (an antibiotic) also known as trimethoprim/sulfamethoxazole;
• diuretics (medicines that increase urine production);
• lithium (a medicine used to treat mental disorders).

The doctor may need to change the dose and/or take other precautions:

• If the patient is taking an ACE inhibitor or aliskiren (see also the information under "When not to take Carzap" and "Warnings and precautions").
• If the patient is taking an ACE inhibitor and a medicine used to treat heart failure, known as a mineralocorticoid receptor antagonist (MRA) (e.g., spironolactone, eplerenone).

Carzap with food, drink, and alcohol

During treatment with Carzap, the doctor should be consulted if the patient plans to consume alcohol. Alcohol may cause dizziness or fainting.

Pregnancy, breastfeeding, and fertility

Pregnancy

If the patient suspects she may be pregnant (or is planning to have a baby), she should consult her doctor. The doctor will usually recommend stopping Carzap before planned pregnancy or as soon as pregnancy is confirmed and recommend taking another medicine instead of Carzap. It is not recommended to take Carzap in early pregnancy and it should not be taken after 3 months of pregnancy, as it may seriously harm the baby.

Breastfeeding

The doctor should be informed about breastfeeding or the intention to breastfeed. It is not recommended to take Carzap during breastfeeding, especially in the case of breastfeeding a newborn or premature baby. The doctor may recommend taking another medicine.

Driving and using machines

During treatment with Carzap, some patients may feel tired and dizzy. If such symptoms occur, the patient should not drive vehicles, use tools, or operate machines.

Carzap contains lactose monohydrate and sodium

Carzap contains lactose monohydrate, which is a type of sugar. If the patient has been diagnosed with intolerance to some sugars, they should contact their doctor before taking Carzap.

The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is considered "sodium-free".

3. How to take Carzap

This medicine should always be taken as directed by the doctor or pharmacist. In case of doubt, the doctor or pharmacist should be consulted.

The following doses of Carzap are available: 8 mg, 16 mg, 32 mg.

It is important to take Carzap every day. Carzap can be taken with or without food. The tablet should be swallowed with water. The tablets should be taken every day at about the same time. This will help the patient remember to take the dose.

High blood pressure:

• The recommended dose of Carzap is 8 mg once daily. The doctor may increase the dose to 16 mg once daily and then to 32 mg once daily, depending on the patient's response to treatment.
• The doctor may recommend a lower initial dose in certain patients, e.g., patients with liver or kidney problems, patients who have lost a lot of fluid, e.g., due to vomiting, diarrhea, or the use of diuretics.
• In black patients, the response to treatment may be weaker if Carzap is used as monotherapy. It may be necessary to use higher doses.

Use in children and adolescents with high blood pressure

Children from 6 to 18 years of age:

The recommended initial dose is 4 mg once daily.

Patient's body weight <50 kg: in patients whose blood pressure is not adequately controlled, the doctor may decide to increase dose a maximum of 8 mg once daily.< p>

Patient's body weight ≥50 kg: in patients whose blood pressure is not adequately controlled, the doctor may decide to increase the dose to 8 mg once daily and then to 16 mg once daily.

Heart failure in adults:

The recommended initial dose of Carzap is 4 mg once daily. The doctor may increase the dose by doubling it, at intervals of at least 2 weeks, to 32 mg once daily. Carzap can be taken with other medicines used to treat heart failure, and the doctor will decide which treatment is most suitable for the patient.

Use of a higher dose of Carzap than recommended

In case of taking a higher dose of Carzap than recommended by the doctor, the doctor or pharmacist should be contacted immediately.

Missing a dose of Carzap

A double dose should not be taken to make up for a missed dose. The next dose should be taken at the usual time.

Stopping treatment with Carzap

If treatment with Carzap is stopped, blood pressure may increase again.

Therefore, treatment with Carzap should not be stopped without consulting the doctor first.

In case of any further doubts about the use of this medicine, the doctor or pharmacist should be consulted.

4. Possible side effects

Like all medicines, Carzap can cause side effects, although not everybody gets them.

It is important for the patient to know that they can occur.

The patient should stop taking Carzap and seek medical help immediately if they experience any of the following allergic reactions:

• difficulty breathing, with or without swelling of the face, lips, tongue, and/or throat
• swelling of the face, lips, tongue, and/or throat, which may cause difficulty swallowing
• severe itching of the skin (with raised bumps)

Carzap may cause a decrease in the number of white blood cells. The patient's resistance to infection may be decreased, and they may experience fatigue, infection, or fever. If such symptoms occur, the doctor should be consulted. The doctor may recommend periodic blood tests to check if Carzap is affecting the blood count (agranulocytosis).

Other possible side effects include:

Common (may affect up to 1 in 10 people)

• Dizziness/spinning sensation
• Headache
• Respiratory tract infection
• Low blood pressure. This may cause fainting or dizziness
• Changes in blood test results: Increased potassium levels in the blood, especially if the patient has kidney problems or heart failure. If the increase is significant, the patient may experience fatigue, weakness, irregular heartbeat, or tingling.
• Affecting kidney function, especially in patients with existing kidney problems or heart failure. In very rare cases, kidney failure may occur.

Very rare (may affect up to 1 in 10,000 people)

• Swelling of the face, lips, tongue, and/or throat
• Decreased number of red or white blood cells. The patient may experience fatigue, infection, or fever
• Skin rash, hives
• Itching
• Back pain, joint and muscle pain
• Changes in liver function, including hepatitis. The patient may experience fatigue, yellowing of the skin and eyes, and flu-like symptoms
• Nausea
• Cough
• Changes in blood test results: Decreased sodium levels in the blood. If the decrease is significant, the patient may experience weakness, lack of energy, or muscle cramps.

Frequency not known (frequency cannot be estimated from the available data)

• Diarrhea.

In children treated for high blood pressure, side effects seem to be similar to those in adults, but they occur more frequently. A very common side effect in children, not reported in adults, is a sore throat. Additionally, side effects such as a runny nose, fever, and rapid heartbeat in children occur frequently, but were not reported in adults.

Reporting side effects

If the patient experiences any side effects, including any side effects not listed in the leaflet, they should inform their doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products,

Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309, website: https://smz.ezdrowie.gov.pl

By reporting side effects, more information can be collected on the safety of the medicine.

5. How to store Carzap

The medicine should be stored out of sight and reach of children.

The medicine should not be used after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated.

There are no special precautions for storage.

Medicines should not be disposed of via wastewater or household waste. The pharmacist should be asked how to dispose of medicines that are no longer needed. This will help protect the environment.

6. Contents of the packaging and other information

What Carzap contains

The active substance of the medicine is candesartan cilexetil.

Each tablet contains 32 mg of candesartan cilexetil.

The other ingredients are: lactose monohydrate, cornstarch, hydroxypropylcellulose (E 463), croscarmellose sodium (E 468), magnesium stearate (E 572), triethyl citrate (E 1505).

What Carzap looks like and contents of the pack

Carzap, 32 mg, is a round, biconvex, white or almost white tablet with a score line on one side and the imprint C/32 on the same side. The diameter of the tablet is approximately 10.5 mm.

The tablet can be divided into equal doses.

The pack sizes are: 14, 28, 56, or 98 tablets.

For more detailed information, the marketing authorization holder or parallel importer should be contacted.

Marketing authorization holder in the Czech Republic, the country of export:

Zentiva, k. s., U Kabelovny 130, 102 37 Prague 10, Czech Republic

Manufacturer:

Zentiva, k. s., U Kabelovny 130, 102 37 Prague 10, Czech Republic

Parallel importer:

Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź

Repackaged by:

Delfarma Sp. z o.o., ul. Św. Teresy od Dzieciątka Jezus 111, 91-222 Łódź

Czech Republic, the country of export, marketing authorization number: 58/747/11-C

Parallel import authorization number: 128/21 Date of approval of the leaflet: 22.12.2022

[Information about the trademark]